Krebs Biochemicals and Industries Operational Benchmarking
₹56.73-5.01%close, 9 Oct 2026
- Market cap
- ₹122 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹40.85 – ₹76.59
Krebs Biochemicals and Industries compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Krebs Biochemicals and Industries sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Krebs Biochemicals & Industries Limited | ₹56.73 | 22.5 | 122 | 1.2% | 30.58 | 14.5% |
| Median (1 Cos) | ₹56.73 | 22.5 | 122 | 1.2% | 30.58 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Kriti Industries (India) Limited operational benchmarking
- Kirloskar Pneumatic Company Limited operational benchmarking
- KRN Heat Exchanger and Refrigeration Limited operational benchmarking
- Kirloskar Industries Limited operational benchmarking
- Ksb Limited operational benchmarking
- Kirloskar Oil Engines Limited operational benchmarking
Trade Krebs Biochemicals and Industries With ATS
Track KREBSBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.